These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36276272)

  • 1. Exosome-Mediated Transfer of miR-3613-5p Enhances Doxorubicin Resistance by Suppression of PTEN Expression in Breast Cancer Cells.
    Luo L; Zhang X; Rousuli Y; Aini A
    J Oncol; 2022; 2022():9494910. PubMed ID: 36276272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteocyte-derived exosomes induced by mechanical strain promote human periodontal ligament stem cell proliferation and osteogenic differentiation via the miR-181b-5p/PTEN/AKT signaling pathway.
    Lv PY; Gao PF; Tian GJ; Yang YY; Mo FF; Wang ZH; Sun L; Kuang MJ; Wang YL
    Stem Cell Res Ther; 2020 Jul; 11(1):295. PubMed ID: 32680565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer.
    Zhao S; Pan T; Deng J; Cao L; Vicencio JM; Liu J; Zhou G; Ng T; Zhang J
    Br J Cancer; 2023 Feb; 128(4):665-677. PubMed ID: 36522479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-202-5p/
    Liu T; Guo J; Zhang X
    Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance.
    Yao S; Yin Y; Jin G; Li D; Li M; Hu Y; Feng Y; Liu Y; Bian Z; Wang X; Mao Y; Zhang J; Wu Z; Huang Z
    Cancer Med; 2020 Aug; 9(16):5989-5998. PubMed ID: 32618144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
    Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
    Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-transmitted miR-769-5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53.
    Jing X; Xie M; Ding K; Xu T; Fang Y; Ma P; Shu Y
    Clin Transl Med; 2022 May; 12(5):e780. PubMed ID: 35522909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
    Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H
    Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183.
    Guo J; Duan Z; Zhang C; Wang W; He H; Liu Y; Wu P; Wang S; Song M; Chen H; Chen C; Si Q; Xiang R; Luo Y
    J Immunol; 2020 Nov; 205(10):2916-2925. PubMed ID: 32989094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
    Yi X; Lou L; Wang J; Xiong J; Zhou S
    Cancer Chemother Pharmacol; 2021 May; 87(5):647-656. PubMed ID: 33544209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal CircPRRX1 Enhances Doxorubicin Resistance in Gastric Cancer by Regulating MiR-3064-5p/PTPN14 Signaling.
    Wang S; Ping M; Song B; Guo Y; Li Y; Jia J
    Yonsei Med J; 2020 Sep; 61(9):750-761. PubMed ID: 32882759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
    Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome miR-371b-5p promotes proliferation of lung alveolar progenitor type II cells by using PTEN to orchestrate the PI3K/Akt signaling.
    Quan Y; Wang Z; Gong L; Peng X; Richard MA; Zhang J; Fornage M; Alcorn JL; Wang D
    Stem Cell Res Ther; 2017 Jun; 8(1):138. PubMed ID: 28595637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertoli cell-derived exosomal MicroRNA-486-5p regulates differentiation of spermatogonial stem cell through PTEN in mice.
    Li Q; Li H; Liang J; Mei J; Cao Z; Zhang L; Luo J; Tang Y; Huang R; Xia H; Zhang Q; Xiang Q; Yang Y; Huang Y
    J Cell Mol Med; 2021 Apr; 25(8):3950-3962. PubMed ID: 33608983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p.
    Liu J; Zhu S; Tang W; Huang Q; Mei Y; Yang H
    Cancer Cell Int; 2021 Jan; 21(1):55. PubMed ID: 33451320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
    Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
    Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1.
    Yang C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
    J Obstet Gynaecol Res; 2021 Nov; 47(11):4037-4048. PubMed ID: 34378285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2.
    Zhang Y; Xia F; Zhang F; Cui Y; Wang Q; Liu H; Wu Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):26. PubMed ID: 30665445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.